Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Larissa Vuitika, biologist, works during the virus inactivation process on March 24, 2020 in Belo Horizonte, Brazil.

Larissa Vuitika, biologist, works during the virus inactivation process on March 24, 2020 in Belo Horizonte, Brazil. (Photo: Pedro Vilela/Getty Images)

Medical Experts Denounce 'Irresponsible' Rush to Covid-19 Vaccine by Russia

"The collateral damage from release of any vaccine that was less than safe and effective would exacerbate our current problems insurmountably."

Andrea Germanos

International medical experts expressed concern Tuesday after Russian President Vladimir Putin announced that his country registered a vaccine for Covid-19—a pronouncement that came before the drug has completed robust clinical trials.

"A vaccine against coronavirus has been registered for the first time in the world this morning," Putin said on state TV.

The Russian leader further claimed that the vaccine developed by the Moscow-based Gamaleya Institute "works quite effectively" and "has passed all the needed checks."

Multiple news reports and comments from experts in the field raised questions about Putin's claims.

"Russia has released no scientific data on its testing and CNN is unable to verify the vaccine's claimed safety or effectiveness," the outlet reported.

According to Reuters:

The Russian vaccine's approval by the Health Ministry comes before trials that would normally involve thousands of participants, commonly known as a Phase III trial. Such trials are usually considered essential precursors for a vaccine to secure regulatory approval.

Additionally, as the Associated Press reported, injections "were studied in only dozens of people for less than two months," though Russian officials said advanced trials would begin Wednesday. From the wire service:

In the meantime, the vaccine will be offered to tens of thousands of people. Deputy Prime Minister Tatyana Golikova said the vaccination of doctors could start as early as this month. Russian authorities have said that medical workers, teachers, and other risk groups will be the first to undergo vaccination.

Dr. Eric Feigl-Ding, an epidemiologist and senior fellow at the Federation of American Scientists, called Russia's rollout of the vaccine ahead of Stage 3 trials "irresponsible."

In a Twitter thread responding to the Washington Post's reporting on Russia's vaccine announcement, Feigl-Ding explained that "phase 3's larger sample size allows much better study of safety signals and in wider range of patients," adding that waiting for that phase to complete would "allow greater confidence."

But, he added, there are more issues at stake:

Those points were echoed by Dr. Ohid Yaqub, senior lecturer in the Science Policy Research Unit at the University of Sussex.

"In terms of safety," Yaqub said in a statement, "skipping phase 3 means trust in this vaccine—and vaccines generally—could be undermined, and it could also give people a false sense of security, if it turns out the vaccine is not actually effective."

"Another important implication is that, if there is widespread diffusion of this vaccine, it may interfere with the testing of future vaccines that are potentially better," said Yaqub.

Feigl-Ding, in his Twitter thread, also stressed that development of a Covid-19 vaccine should be marked by global cooperation.

"Phase 3 gives not just confidence in safety in wider array of people, and hence picking up effects in more narrow subgroups of people, but also allow well it truly prevents infection in real world setting. And both of those are key. Let's focus: Quality over warp speed," he wrote.

Danny Altmann, Professor of Immunology at Imperial College London, expressed similar skepticism to Russia's announcement, saying in a statement that the "bar is necessarily set very high for criteria that must be satisfied for approval after Phase 3 clinical trials" and warned that the "collateral damage from release of any vaccine that was less than safe and effective would exacerbate our current problems insurmountably."

"I hope these criteria have been followed" with the Russian vaccine, said Altmann. "We are all in this together."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

'Grim and Alarming' UN Report Details 'Catastrophic' Global Failure on Climate

"We are not going in the right direction," warns the head of the World Meteorological Organization.

Andrea Germanos ·


Analysis Shows Facebook Allows 99% of Climate Disinformation to Go Unchecked

The new study coincided with Facebook's new initiative to combat climate lies, which civil society groups criticized as "too little, too late."

Jake Johnson ·


Sanders Says There's 'No Excuse' for Any Democrat to Oppose Lowering Drug Prices

"Now is the time for Congress to show courage and stand up to the greed of the pharmaceutical industry."

Jake Johnson ·


Covid-19 Vaccine Makers Blasted for 'Unconscionable Profits,' Monopolies, and Low Taxes

"Big Pharma's business model—receive billions in public investments, charge exorbitant prices for lifesaving medicines, pay little tax—is gold dust for wealthy investors and corporate executives but devastating for global public health."

Common Dreams staff ·


UN Human Rights Chief Calls for Global Halt to Sales of Dangerous AI Technologies

"The power of AI to serve people is undeniable, but so is AI's ability to feed human rights violations at an enormous scale with virtually no visibility."

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo